Understanding The Clinical Research Organization and The Business of Falsifying Bioequivalence
Executive Summary Falsifying bioequivalence is commonly done by what is called clinical research organizations or CROs. Introduction A significant issue with falsifying bioequivalence is the companies paid to prove rather than test bioequivalence. These are called Clinical Research Organizations or CROs.